Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableLooking for participantsNCT04751396
What this trial is testing

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Who this might be right for
Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more
M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Ended earlyNCT01814046
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Who this might be right for
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Very early researchActive Not RecruitingNCT05358938
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 22
Early research (Phase 1)Study completedNCT00001439
What this trial is testing

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Who this might be right for
Melanoma
National Cancer Institute (NCI) 255
Testing effectiveness (Phase 2)Study completedNCT00308607
What this trial is testing

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Turku 27
Not applicableStudy completedNCT02975700
What this trial is testing

PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma

Who this might be right for
Melanoma
Daiichi Sankyo Co., Ltd. 6
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Testing effectiveness (Phase 2)Temporarily pausedNCT01988831
What this trial is testing

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

Who this might be right for
Stages III Skin MelanomaStages II Skin MelanomaStage IB Skin Melanoma
University Hospital, Geneva 450
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT03620019
What this trial is testing

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Who this might be right for
Melanoma Stage IiiMelanoma Stage IvMelanoma+2 more
UNC Lineberger Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableEnded earlyNCT02650492
What this trial is testing

Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Clinical Laserthermia Systems AB 2
Testing effectiveness (Phase 2)Study completedNCT01290536
What this trial is testing

Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases

Who this might be right for
Colorectal NeoplasmsNeuroendocrine TumorsCholangiocarcinoma+2 more
Nicholas Fidelman, MD 42
Not applicableActive Not RecruitingNCT07022457
What this trial is testing

UK ENcorafenib and BInimetinib Real-world Study in Melanoma

Who this might be right for
Metastatic Melanoma, BRAF V600 Mutation Positive
Pierre Fabre Ltd 50
Early research (Phase 1)Looking for participantsNCT06889766
What this trial is testing

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

Who this might be right for
Advanced MelanomaMelanoma MetastaticSarcoma
Centre Hospitalier Universitaire Vaudois 9
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Testing effectiveness (Phase 2)UnknownNCT02625337
What this trial is testing

Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients

Who this might be right for
Metastatic Melanoma
The Netherlands Cancer Institute 32
Very early researchStudy completedNCT02316795
What this trial is testing

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

Who this might be right for
Breast CancerCancer of BreastCancer of the Breast+2 more
Washington University School of Medicine 20
Next Page